The Zhitong Finance App learned that True Health Care (02697) rose by more than 13%, and the intraday high was HK$850, which reached a new listing high. As of press release, it rose 13.29% to HK$844, with a turnover of HK$35.37,800.
According to the news, recently, the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine introduced an artificial intelligence thoracic surgery robot to accurately locate small lung nodules through AI to upgrade from traditional “blind investigation” to “precise sniper”, greatly improving the efficiency of early lung cancer diagnosis and treatment, and bringing patients more accurate and minimally invasive treatment plans. Industry insiders believe that as technologies such as AI image recognition, 3D reconstruction, and robot-assisted intervention continue to mature, the medical robot industry is accelerating into the commercial application stage, covering many high-value tracks such as lung cancer, orthopedics, and neurosurgery, and the industry has broad room for growth.
According to reports, benefiting from the trend of medical intelligence upgrading, the “first puncture surgical robot” True Health Care continues to advance the layout of artificial intelligence and digital medical care. The company continues to improve product systems in fields such as smart medicine, AI-assisted diagnosis and treatment, and medical informatization, and actively promotes the application of artificial intelligence technology in hospital clinical scenarios. As the country continues to promote the digitalization of medical care and the accelerated implementation of new technologies such as AI medical robots and accurate diagnosis and treatment, True Health Care is expected to benefit from an increase in industry prosperity and further open up room for long-term growth.